2 completed, 2 unknown. 3 Phase 2, 1 Not applicable, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 2, Unknown 1 |
| Not applicable | 1 | Unknown 1 |
| Phase 3 | 1 | Unknown 1 |
Follow Childhood-Onset Fluency Disorder: new trials by email Literature Review of Childhood-Onset Fluency Disorder trials Research Report on Childhood-Onset Fluency Disorder
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Stimulation of the Thalamus to Ameliorate Persistent Disfluency System On, System off - Persistent Developmental Stutter, Childhood-Onset Fluency Disorder (Stuttering) | Not applicable | Unknown | University of British Columbia | 3 | 2023-11-01 | 2023-10-12 |
| A 10-week Efficacy Study of NOE-105 in Childhood Onset Fluency Disorder (Orpheus) NOE-105, Placebo - Childhood-Onset Fluency Disorder | Phase 2 | Completed | Noema Pharma AG | 75 | 2022-07-25 | 2026-02-20 |
| Effects of Ecopipam or Placebo in Adults With Stuttering (Speak Freely) Ecopipam, Placebo - Childhood-Onset Fluency Disorder (Stuttering) | Phase 2 | Completed | Emalex Biosciences Inc. | 68 | 2020-10-22 | 2026-09-23 |
| Efficacy and Tolerability of Ecopipam in Adults With Childhood Onset Fluency Disorder (Stuttering). Ecopipam 50mg, Ecopipam 100mg - Stuttering, Adult, Childhood-onset Fluency Disorder | Phase 2 / Phase 3 | Unknown | Gerald Maguire, MD | 10 | 2016-09-01 | 2016-10-26 |
Stuttering (3) · Communication Disorders (2) · Language Disorders (1) · Speech Disorders (1)
Mental Disorders (4) · Neurodevelopmental Disorders (4) · Nervous System Diseases (3) · Neurobehavioral Manifestations (3) · Neurologic Manifestations (3) · Pathological Conditions, Signs and Symptoms (3) · Signs and Symptoms (3) · Communication Disorders (2) · Language Disorders (2) · Speech Disorders (2)
ecopipam (2)
Emalex Biosciences Inc. (1) · Gerald Maguire, MD (1) · Noema Pharma AG (1) · University of British Columbia (1)
United States (3) · Australia (1)
Atul R Mahableshwarkar, MD, DFAPA (1) · Gerald A Maguire, M.D. (1)
PMID 10917410, PMID 12849360, PMID 15026214, PMID 15212606, PMID 15328899, PMID 20075648, PMID 24434529